Atlas Trials

A Study of Peldesine (BCX-34) in HIV-Infected Patients

Clinical trial NCT00002237 · COMPLETED

Trial details

NCT number
NCT00002237
Sponsor
BioCryst Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV Infections

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.